Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy

Proteomics

Volumn 15, Issue 21, 2015, Pages 3722-3730

  Rood, Ilse M ^a   Merchant, Michael L ^b   Wilkey, Daniel W ^b   Zhang, Terry ^c   Zabrouskov, Vlad ^c   van der Vlag, Johan ^a   Dijkman, Henry B ^a   Willemsen, Brigith K ^a   Wetzels, Jack F ^a   Klein, Jon B ^b,d   Deegens, Jeroen K ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c Thermo Fisher Scientific   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biomedicine; Extracellular vesicles; Focal segmental glomerulosclerosis; Idiopathic membranous nephropathy; LIMP 2; Microvesicles

Indexed keywords

BIOLOGICAL MARKER; CELL PROTEIN; IMMUNOGLOBULIN G; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; PROTEOME; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; SCARB2 PROTEIN, HUMAN; SCAVENGER RECEPTOR;

ANTIBODY BLOOD LEVEL; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; UPREGULATION; PATHOLOGY; URINE;

GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; RECEPTORS, SCAVENGER;

EID: 84945152188     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201500127     Document Type: Article

References (29)

1. Haas, M., IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies. Am. J. Kidney Dis. 1994, 23, 358-364.
2. Ohtani, H., Wakui, H., Komatsuda, A., Okuyama, S. et al., Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol. Dial. Transplant. 2004, 19, 574-579.
3. Glassock, R. J., The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am. J. Kidney Dis. 2010, 56, 157-167.
4. Beck, L. H., Jr., Bonegio, R. G., Lambeau, G., Beck, D. M. et al., M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 2009, 361, 11-21.
5. Tomas, N. M., Beck, L. H., Jr., Meyer-Schwesinger, C., Seitz-Polski, B. et al., Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N. Engl. J. Med. 2014, 371, 2277-2287.
6. Hofstra, J. M., Beck, L. H., Jr., Beck, D. M., Wetzels, J. F., Salant, D. J., Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol. 2011, 6, 1286-1291.
7. Beck, L. H., Jr., Salant, D. J., Membranous nephropathy: recent travels and new roads ahead. Kidney Int. 2010, 77, 765-770.
8. Prunotto, M., Carnevali, M. L., Candiano, G., Murtas, C. et al., Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J. Am. Soc. Nephrol. 2010, 21, 507-519.
9. Bruschi, M., Carnevali, M. L., Murtas, C., Candiano, G. et al., Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens. J. Proteomics 2011, 74, 2008-2017.
10. Thongboonkerd, V., McLeish, K. R., Arthur, J. M., Klein, J. B., Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 2002, 62, 1461-1469.
11. Pisitkun, T., Shen, R. F., Knepper, M. A., Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U S A 2004, 101, 13368-13373.
12. Gonzales, P., Pisitkun, T., Knepper, M. A., Urinary exosomes: is there a future? Nephrol. Dial. Transplant. 2008, 23, 1799-1801.
13. Simpson, R. J., Jensen, S. S., Lim, J. W., Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8, 4083-4099.
14. Rood, I. M., Deegens, J. K., Merchant, M. L., Tamboer, W. P. et al., Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int. 2010, 78, 810-816.
15. Saftig, P., Schroder, B., Blanz, J., Lysosomal membrane proteins: life between acid and neutral conditions. Biochem. Soc. Trans. 2010, 38, 1420-1423.
16. Ohsumi, Y., Ishikawa, T., Kato, K., A rapid and simplified method for the preparation of lysosomal membranes from rat liver. J. Biochem. 1983, 93, 547-556.
17. Reczek, D., Schwake, M., Schroder, J., Hughes, H. et al., LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell 2007, 131, 770-783.
18. Eskelinen, E. L., Tanaka, Y., Saftig, P., At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 2003, 13, 137-145.
19. Kuronita, T., Eskelinen, E. L., Fujita, H., Saftig, P. et al., A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J. Cell Sci. 2002, 115, 4117-4131.
20. Saftig, P., Klumperman, J., Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 2009, 10, 623-635.
21. Gamp, A. C., Tanaka, Y., Lullmann-Rauch, R., Wittke, D. et al., LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum. Mol. Genet. 2003, 12, 631-646.
22. Desmond, M. J., Lee, D., Fraser, S. A., Katerelos, M. et al., Tubular proteinuria in mice and humans lacking the intrinsic lysosomal protein SCARB2/Limp-2. Am. J. Physiol. Renal Physiol. 2011, 300, F1437-F1447.
23. Knipper, M., Claussen, C., Ruttiger, L., Zimmermann, U. et al., Deafness in LIMP2-deficient mice due to early loss of the potassium channel KCNQ1/KCNE1 in marginal cells of the stria vascularis. The Journal of physiology 2006, 576, 73-86.
24. Berkovic, S. F., Dibbens, L. M., Oshlack, A., Silver, J. D. et al., Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis. Am. J. Human Genet. 2008, 82, 673-684.
25. Ronco, P., Debiec, H., Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat. Rev. Nephrol. 2012, 8, 203-213.
26. Murtas, C., Ravani, P., Ghiggeri, G. M., New insights into membranous glomerulonephritis: from bench to bedside. Nephrol. Dial. Transplant. 2011, 26, 2428-2430.
27. Debiec, H., Ronco, P., PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N. Engl. J. Med. 2011, 364, 689-690.
28. Debiec, H., Martin, L., Jouanneau, C., Dautin, G. et al., Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy. Am. J. Transplant. 2011, 11, 2144-2152.
29. Murtas, C., Bruschi, M., Candiano, G., Moroni, G. et al., Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin. J. Am. Soc. Nephrol. 2012, 7, 1394-1400.